Raneburger; Johannes

Patent Applications and Registrations

Patent applications and USPTO patent grants for Raneburger; Johannes.The latest application filed is for "crystalline form ii of darolutamide".

Company Profile

1.9.16

Raneburger; Johannes - Kundl AT
Raneburger; Johannes - Worgl AT
Raneburger; Johannes - Professor-Groemer-Weg AT
Raneburger; Johannes - Woergl AT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Crystalline Form II of Darolutamide App 20210087175 - Adamer; Verena ; et al.	2021-03-25
Pharmaceutical composition containing rifaximin alpha and delta Grant 10,576,065 - Raneburger	2020-03-03
Penicillin retard composition for intramuscular injection Grant 10,159,661 - Bitter , et al. Dec	2018-12-25
Pharmaceutical Composition Containing Rifaximin Alpha & Delta App 20180169076 - RANEBURGER; Johannes	2018-06-21
Penicillin Retard Composition For Intramuscular Injection App 20180036291 - Bitter; Christoph ; et al.	2018-02-08
Pharmaceutical Composition Containing Crystalline Macitentan App 20180008603 - Stefinovic; Marijan ; et al.	2018-01-11
Pharmaceutical Composition Consisting of Ceftaroline Fosamil Acetic Acid Solvate Particles Arginine Particles, Both Having A Specific Particle Size Distribution App 20170326153 - Raneburger; Johannes	2017-11-16
Pharmaceutical Compositions of Edoxaban App 20170231969 - Raneburger; Johannes ; et al.	2017-08-17
Pharmaceutical composition containing crystalline macitentan Grant 9,730,932 - Stefinovic , et al. August 15, 2	2017-08-15
Powder mixtures for antibiotic dry syrup formulations Grant 9,566,337 - Scheler , et al. February 14, 2	2017-02-14
Powder Mixtures For Antibiotic Dry Syrup Formulations App 20160151501 - Schelere; Stefan ; et al.	2016-06-02
Tablet With Increased Drug Load Of Odanacatib App 20160106679 - Raneburger; Johannes ; et al.	2016-04-21
Tablet With Increased Drug Load Of Odanacatib App 20160081937 - Raneburger; Johannes ; et al.	2016-03-24
Pharmaceutical Composition Containing Crystalline Macitentan App 20160074398 - Stefinovic; Marijan ; et al.	2016-03-17
Pharmaceutical composition containing crystalline sorafenib tosylate Grant 9,227,938 - Scheler , et al. January 5, 2	2016-01-05
Pharmaceutical Composition Containing Crystalline Sorafenib Tosylate App 20150080435 - Scheler; Stefan ; et al.	2015-03-19
Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts Grant 8,293,272 - Burghart , et al. October 23, 2	2012-10-23
Kit Of Parts Comprising An Acid Labile And An Acid Resistant Pharmaceutically Active Ingredient App 20100040598 - Raneburger; Johannes ; et al.	2010-02-18
Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts App 20070014851 - Burghart; Walter ; et al.	2007-01-18
Crystalline cefdinir App 20060122165 - Daemon; Otto ; et al.	2006-06-08
Compositions comprising cefuroxime axetil Grant 6,727,243 - Jennewein , et al. April 27, 2	2004-04-27
Pharmaceutical composistions App 20040043981 - Horkovics-Kovats, Stefan ; et al.	2004-03-04
Agglomerates of .beta.-lactam antibiotics and processess for making agglomerates Grant 6,440,462 - Raneburger , et al. August 27, 2	2002-08-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.